https://gw610agonist.com/evalu....ation-involving-cruc
Through a descriptive study, the acute impact of intranasal ketamine on refractory chronic migraine was examined, revealing reduced headache intensity, improved quality of life, and relatively tolerable adverse events. Intranasal ketamine, despite its adverse events, remained an effective treatment for most patients, who chose to continue using it. Given the risk of overuse, this intervention should only be made available to those undeniably in need of a more
Like
Comment
Share
